India bans combination cold medicines for children under 4 over safety risks
The Indian government has restricted fixed-dose combination cold medicines containing chlorpheniramine maleate and phenylephrine hydrochloride for young children. The ban targets children under the age of four, citing potential health risks associated with these combinations. Authorities noted that safer treatment alternatives are available for this age group. Drug manufacturers are now required to display prominent warnings on labels of all affected products. The regulatory decision follows thorough reviews and formal recommendations from expert medical committees.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.
Discussion (0)
Log in to join the discussion and vote.
Log in